Top Data Analytics Companies in NYC, NY (311)

Strong Market Position & Advantage: Leadership positions across biscuits (#1) and chocolate (#2), anchored by iconic brands and a presence in 150+ countries, support pricing power and distribution reach. Category and geographic breadth are cited as underpinning mid‑term growth capacity.

Resilient & Sustainable Growth: Net revenues and organic net revenue increased in 2025 and remained positive into 2026 despite a tougher cost environment and moderating pace. Management signals potential to reaccelerate profitable growth as cocoa costs stabilize and productivity programs take hold.

Healthy Cash Flow: Guidance for 2026 targets approximately $3 billion in free cash flow, alongside maintained capital returns such as a dividend increase. This cash generation supports continued reinvestment behind brands and execution.

Strong Revenue Growth: Recent results show Move’s revenue rising year over year in fiscal Q4 2026, capping seven consecutive quarters of growth. Full‑year gains in the Digital Real Estate Services segment and improved revenue per lead from premium offerings reinforce this momentum.

Strong Market Position & Advantage: Independent rankings place Realtor.com as the No. 2 U.S. real‑estate portal with a sizable share of category visits. Engagement depth leads peers, with visits per unique user ahead of Zillow, Redfin, and Homes.com.

Diversified Revenue Streams: Management highlights growth from seller, new homes, and rentals alongside premium lead products such as RealPRO Select. This mix shift is credited with lifting monetization, including revenues per lead.

Strong Market Position & Advantage: G2 has ranked Monte Carlo the #1 Data Observability platform for multiple consecutive quarters, and the company highlights enterprise wins such as Dell, American Airlines, Live Nation, and DraftKings. These signals point to prominent positioning in its category through 2025–2026.

Innovation-Driven Growth: Recent launches expand the platform from data observability into data + AI/agent trust, including Agent Observability, an Operations Agent, and unstructured data monitoring. New integrations and an EU hosting option broaden use cases and geographic reach.

Investor Backing & Capital Strength: A substantial Series D in 2022 at around a $1.6B valuation provides runway to invest through recent years. This capital base underpins expansion in product and go‑to‑market alongside visible enterprise traction.

Strong Revenue Growth: Repeated inclusion in the FT1000 rankings and references to rising revenues in Polish registry summaries indicate multi-year top-line expansion. Company materials also describe continued scaling across markets and campaigns.

Product Line Growth: The March 2026 launch of rtb.com adds a self‑service channel aimed at SMEs, extending beyond managed‑service retargeting. This move broadens the addressable market and introduces a new go‑to‑market motion.

Future-Ready Strategy: Early, visible work on Google’s Privacy Sandbox and ISO/IEC 27001:2022 certification signal preparedness for a cookieless and enterprise‑grade future. Participation on the NAI Board further underscores alignment with evolving privacy and industry standards.

Profitability: Operating earnings are reported at nearly $3.9 billion for 2025, an all-time high. A record estimated 2026 policyowner dividend further signals strong underlying earnings capacity.

Strong Revenue Growth: Total sales surpassed $43 billion in 2025, up from 2024 levels. Company disclosures also indicate higher total revenue year over year.

Investor Backing & Capital Strength: Total adjusted capital increased to $34.4 billion in 2025, alongside affirmations of very high financial strength ratings from major agencies. These indicators are presented as continued balance-sheet resilience.

Strong Revenue Growth: Management disclosed 11 consecutive quarters of top-line expansion as of Q2 2026, with guidance indicating continued increases post‑IPO. Observations across filings and coverage describe multi‑quarter momentum rather than a one‑off spike.

Investor Backing & Capital Strength: A completed IPO and a prior minority investment from General Atlantic alongside Blackstone signal institutional confidence and provide balance‑sheet flexibility. Proceeds were used in part to reduce debt, supporting capacity for further expansion.

Innovation-Driven Growth: The Cortex AI platform is presented as a core differentiator driving performance gains across a unified DSP/SSP stack. Product updates and shortened learning cycles are highlighted as catalysts for advertiser and publisher adoption.

Investor Backing & Capital Strength: Back-to-back Series D ($118M, Feb 2026) and Series E ($100M, May 2026) at step-up valuations to roughly $1.35B and $2.74B point to ample runway and strong investor confidence. Participation from firms such as Index Ventures, Kleiner Perkins, Sequoia, Thrive, Founders Fund, Redpoint, and Kaiser Permanente Ventures underscores capital strength.

Strong Revenue Growth: Company disclosures cite approximately $200M in gross annual recurring revenue with revenue more than doubling for five consecutive years, including over 130% year-over-year growth noted in early 2026. Nearly 800 customers and millions of covered members are also cited as evidence of expanding commercial scale.

Strategic Partnerships: New collaborations in 2026 with Priority Health and Atlantic Health expand distribution into health plan and regional employer channels. Priority Health separately confirmed the partnership and product launch.

Profitability: Adjusted EBITDA and ex‑TAC gross profit are rising at double‑digit rates, with Q2 margins expanding and management raising full‑year profitability guidance. This points to increasing operating leverage even as mix shifts favor higher‑margin revenue.

Strategic Partnerships: A 30‑year exclusive native‑ads agreement with Yahoo is live globally and framed as a multi‑year growth driver with sizable revenue potential. Recent publisher wins such as Fox News further extend distribution that supports current results and the outlook.

Innovation-Driven Growth: Momentum in the Realize performance offering and AI initiatives like DeeperDive are cited as contributors to improved results and raised guidance. These offerings indicate continued product evolution beyond classic native formats.

Investor Backing & Capital Strength: Investor support is underscored by a $50M Series B in June 2025 led by TELUS Global Ventures, with round details corroborated by business press and investor materials. The capital is described as earmarked to scale the platform and operations globally.

Market Expansion: Geographic growth is explicitly planned across North America, Europe, and APAC, tied to the 2025 funding use-of-proceeds. Company materials also highlight adoption by large global F&B brands, indicating expanding enterprise footprint.

Innovation-Driven Growth: Product momentum is visible in the launch and evolution of TasteGPT and agentic AI tools, alongside a rebuilt Consumer Insights Dashboard in 2026. Trade and company sources note continued updates and category-focused AI capabilities.

Strong Revenue Growth: Revenue expanded rapidly, with FY2025 up 83% to about $1.27B and Q1/Q2 2026 up 36% and 22% year over year, respectively. Management also raised 2026 revenue guidance to approximately $1.595–$1.605B.

Diversified Revenue Streams: Both Diagnostics and Data & Applications are expanding, with Diagnostics up 34.7% in Q1 and 20% in Q2 2026 and Insights/data licensing up 36% in Q2 alongside about $200M in new licenses. Rising oncology test volumes (28–31% YoY) and accelerating MRD tests (~4,700 in Q4 2025 to ~9,000 in Q2 2026) reinforce multiple growth engines.

Profitability: The company achieved its first GAAP-profitable quarter in Q2 2026 (net income about $5.6M; Adjusted EBITDA ~$8.0M). Guidance points to further improvement in 2026, indicating progress toward sustained profitability.

Strong Revenue Growth: Revenue is advancing at a double‑digit pace in early 2026, with successive quarters outperforming internal targets and full‑year guidance raised. Momentum is driven by U.S. Financial Services and improving International trends.

Profitability: Earnings are expanding, with adjusted EBITDA and adjusted EPS up year over year and full‑year guidance implying further gains. Absolute EBITDA improved even as the company invested and integrated recent acquisitions.

Market Expansion: Reach is widening through improved performance in Canada, the U.K., and India, alongside completed acquisitions in Mexico and a mobile division that extend capabilities. These moves contributed to stronger reported results and a higher outlook.

Investor Backing & Capital Strength: Formation Bio closed a $372M Series D on June 26, 2024 led by a16z with significant participation from Sanofi, bringing total funding to over $600M and at a material step-up in valuation. The capital is directed toward expanding its drug pipeline and AI platform.

Strategic Partnerships: A first‑in‑class AI collaboration with Sanofi and OpenAI (announced May 2024) has already produced Muse, an AI tool for patient recruitment. Additional partnering activity includes Sanofi’s 2025 deal for gusacitinib via a Formation subsidiary, signaling expanding commercial and technology ties.

Product Line Growth: Multiple in‑licensing moves in 2025–2026 (e.g., a CNS‑penetrant TYK2 inhibitor, a miR‑124 activator, and an anti‑CD226 program) broaden the portfolio. The first participant was dosed in a Phase 1 trial (BLKR201) on June 9, 2026, marking concrete clinical progression.

Strong Revenue Growth: Recent quarters show sharp year-over-year increases in net revenue, surpassing the billion‑dollar mark per quarter as GMV and transaction volume expand. Feedback suggests this momentum is broad‑based across multiple operating metrics rather than isolated to a single line item.

Profitability: GAAP operating income and net income turned positive in fiscal 2026 quarters, signaling improved operating leverage and margins. Company filings indicate this profitability coincides with higher volumes rather than coming solely from cost actions.

Market Expansion: Active consumers and merchants increased meaningfully, with transactions per active consumer also rising. Direct‑to‑consumer offerings—especially the Affirm Card—scaled rapidly and diversified activity beyond the largest partners.

Strong Revenue Growth: Revenue rose 23% in FY2026 to about $2.46B, with Q4 FY2026 up 27% year over year and Q1 FY2027 up 25% year over year. Management guided FY2027 revenue to roughly $2.92–$2.96B, indicating continued double‑digit expansion.

Healthy Cash Flow: Operating cash flow reached about $505M in FY2026, and management highlighted “rule‑of‑40” performance in Q4. Recent updates also cite strong free cash flow in Q1 FY2027.

Innovation-Driven Growth: Atlas is the primary growth engine and reached roughly 73% of FY2026 revenue (about 75% in Q1 FY2027), with Atlas revenue growing around the high‑20s to ~30% year over year in recent periods. AI‑related additions such as vector search and Automated Embeddings (via Voyage AI) are positioned as catalysts for further adoption.

Strong Revenue Growth: Revenue accelerated 22% year over year in Q2 2026 to $98.7 million, which management called the strongest quarterly growth in over four years, and full‑year 2026 revenue guidance was raised to $400–$410 million. GMV reviewed also increased 13% year over year, reinforcing top‑line momentum.

Healthy Cash Flow: Q2 2026 delivered $12.9 million in free cash flow, and the company ended the quarter with roughly $223.6 million in cash and investments with no debt. Management also signaled expectations for robust full‑year cash generation.

Market Expansion: New logo wins across regions and verticals, growth in non‑card/ACH risk models, and adoption of the ARIA AI assistant contributed to Q2 performance. Recent partnerships (e.g., Marqeta; SB Payment Service; Paygent; Outpayce/Amadeus) further broaden distribution and demand.

Investor Backing & Capital Strength: A $70M Series C announced on May 28, 2025 and the April 30, 2025 acquisition of Hashboard signal substantial resources and scale-up momentum. These moves indicate ample runway to fund product development and go-to-market execution.

Strategic Partnerships: Recognition at Snowflake Summit 2026 as Product Partner of the Year for Agentic Analytics and deep Snowflake integrations point to strong ecosystem alignment. This partner-led motion can accelerate adoption within a key data cloud.

Product Line Growth: Since late 2024 the company has shipped new capabilities (e.g., Explore drag-and-drop analytics; enhanced AI/agent features like Agent Observability) and expanded into BI via the Hashboard acquisition. A visible 2025–2026 release cadence suggests active investment and a broader user footprint.

Resilient & Sustainable Growth: Growth is described as measured and predictable, with signals such as modest headcount expansion, sustained operating scale, and continued momentum rather than volatility.

Innovation-Driven Growth: Recent major releases across IRIS/IRIS for Health/Health Connect and new AI-focused offerings indicate ongoing R&D velocity that broadens capabilities and use cases.

Strong Market Position & Advantage: Repeated industry accolades for Shared Care Records/HIE and regional acute EHRs in 2026 point to durable competitive standing in core healthcare markets.

Strong Market Position & Advantage: Independent market-share analysis places Celonis at the front of its category while the market itself expands. This positioning suggests the company is capturing growth in a segment it leads.

Future-Ready Strategy: External recognition for long-term growth potential signals confidence in Celonis’s strategy, innovation, and talent pipeline. This points to preparedness as the space broadens from process mining into process intelligence and AI-enabled workflows.

Strategic Partnerships: A new alliance with a major data and AI platform provider expands product integrations and go-to-market reach into enterprise AI workflows. Such ecosystem momentum supports broader adoption and commercial expansion.

Investor Backing & Capital Strength: Recent funding from Blackstone Growth—$100 million in January 2026 at a reported $500–700 million valuation—signals strong external confidence and provides runway to scale. Company communications describe the capital as intended to fuel continued growth at scale.

Strong Revenue Growth: Multiple recent job postings describe revenue up roughly 10x over the last four years, reflecting a fast-growth trajectory. These statements frame the business as expanding rapidly across its core offerings.

Strong Hiring & Retention: Company materials and LinkedIn indicate the team grew to more than 200 employees in 2025 with headcount up nearly 5x over four years, and the listed company-size band of 201–500 suggests ongoing expansion. Active hiring posts reinforce that scaling is underway.

Strong Revenue Growth: Revenue rose 11% year over year in Q2 2026, while contribution ex‑TAC increased 17% and management raised full‑year 2026 growth targets. Recent periods also show steady gains, including FY2025 revenue up about 7% and contribution ex‑TAC up 10%.

Profitability: Adjusted EBITDA grew 30% year over year in Q2 2026 with a 37% margin, and net income increased to $19.4M from $11.1M. FY2025 adjusted EBITDA rose 18%, indicating expanding operating leverage.

Strong Market Position & Advantage: CTV momentum is supported by broad‑based publisher demand and SpringServe differentiation, with CTV contribution ex‑TAC up 36% to $97.1M and reaching 51% of total. Company materials consistently position the firm as the largest independent SSP and a top player in CTV.